This announcement is a separate document:
桂林三金：董事会审计委员会议事规则（2024年4月修订）
Guilin Sanjin Pharmaceutical: Board Audit Committee Rules of Procedure (Revised April 2024)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.